BURL Concepts

BURL Concepts

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

BURL Concepts is a private, pre-revenue medical device startup based in San Francisco, founded in 2020. The company is developing the SONAS® system, a portable ultrasound-based platform combined with a microbubble solution, designed to non-invasively assess and monitor cerebral blood flow in real-time at the bedside. Its primary target is the stroke diagnosis and monitoring market, seeking to offer a cost-effective alternative to more expensive and less accessible imaging modalities like CT perfusion or MRI. The technology is not yet available for sale in the United States, indicating it is in a pre-commercial stage, likely seeking regulatory clearance.

NeurologyNeurovascular

Technology Platform

SONAS® ultrasound platform utilizing a microbubble contrast solution for non-invasive, real-time, bedside assessment and monitoring of cerebral blood flow and intracranial pressure.

Opportunities

The massive global burden of stroke creates a urgent need for rapid, low-cost, and accessible diagnostic tools.
SONAS®'s portability and bedside capability could enable use in resource-limited settings and expand monitoring beyond traditional imaging suites, opening new care delivery models.

Risk Factors

The company faces significant technical validation and regulatory hurdles to prove clinical efficacy and secure FDA clearance.
Post-approval, market adoption and securing insurance reimbursement against established standards of care (CT/MRI) present major commercial challenges.

Competitive Landscape

Competition includes large medtech firms offering advanced CT and MRI perfusion imaging, as well as other companies developing non-invasive cerebral monitoring technologies (e.g., transcranial Doppler systems, optical methods). BURL must differentiate on cost, portability, and ease-of-use.